By Frank Prenesti
Date: Wednesday 11 May 2022
LONDON (ShareCast) - (Sharecast News) - Private hospital group Spire Healthcare maintained annual guidance despite disruption at the start of the year from the Covid Omicron variant.
"Notwithstanding the disruption in the first quarter due to the Omicron variant, we are satisfied with our performance in the first four months of 2022," Spire said ahead of its annual shareholder meeting on Wednesday.
"Accordingly, whilst we are yet to enter our busiest trading period, we reiterate our outlook for the full year, as set out in our full-year 2021 results announcement."
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 217.50p |
Change Today | 1.00p |
% Change | 0.46 % |
52 Week High | 266.00p |
52 Week Low | 215.00p |
Volume | 10,834 |
Shares Issued | 403.40m |
Market Cap | £877.39m |
Beta | 0.80 |
RiskGrade | 165 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 5 |
Buy | 2 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 8 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 23-May-24 | 25-May-23 |
Paid | 21-Jun-24 | 23-Jun-23 |
Amount | 2.10p | 0.50p |
Time | Volume / Share Price |
08:41 | 1,372 @ 217.25p |
08:30 | 1,100 @ 217.50p |
08:30 | 962 @ 217.50p |
08:27 | 4,500 @ 217.25p |
08:12 | 166 @ 217.50p |
CEO | Justin Ash |
CFO | Harbant Samra |
You are here: research